Eosinophil cationic protein and immunoglobulin levels in bronchoalveolar lavage fluid obtained from patients with chronic eosinophilic pneumonia

European Respiratory Journal

Volumn 9, Issue 12, 1996, Pages 2488-2493

  Boomars, K A ^a   Van Velzen Blad, H ^a   Mulder, P G H ^b   Koenderman, L ^c   Lammers, J W J ^c   Van den Bosch, J M M ^a  

^a ST ANTONIUS HOSPITAL   (Netherlands)

^b ERASMUS UNIVERSITY ROTTERDAM   (Netherlands)

^c UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

bronchoalveolar lavage; chronic eosinophilic pneumonia; eosinophil cationic protein; immunoglobulins

Indexed keywords

EOSINOPHIL CATIONIC PROTEIN; IMMUNOGLOBULIN A;

ARTICLE; ASTHMA; CLINICAL ARTICLE; CONTROLLED STUDY; DEGRANULATION; HUMAN; LOEFFLER PNEUMONIA; LUNG LAVAGE; PRIORITY JOURNAL;

EID: 0029959324     PISSN: 09031936     EISSN: None     Source Type: Journal    
DOI: 10.1183/09031936.96.09122488     Document Type: Article

References (28)

1. Jederlinic PJ, Sicilian L, Gaensler EA. Chronic eosinophilic pneumonia: a report of 19 cases and a review of the literature. Medicine (Baltimore) 1988; 67: 154-162.
2. Carrington CB. Eosinophilic reactions in the lung. N Engl J Med 1969; 280: 787-798.
3. Pearson DL, Rosenow EC. Chronic eosinophilic pneumonia (Carrington's): a follow-up study. Mayo Clin Proc 1978; 53: 73-78.
4. Hayakawa H, Sato A, Toyoshima M, Imokawa S, Taniguchi M. A clinical study of idiopathic eosinophilic pneumonia. Chest 1994; 105: 1462-1466.
5. Naughton M, Fahy J, Fitz Gerald MX. Chronic eosinophilic pneumonia: a long-term follow-up of 12 patients. Chest 1993; 103: 162-165.
6. Fox B, Seed WA. Chronic eosinophilic pneumonia. Thorax 1980; 35: 570-580.
7. Gonzalez EB, Swedo JL, Rajaraman S, Daniels JC, Grant JA. Ultrastructural and immunohistochemical evidence for release of eosinophilic granules in vivo: cytotoxic potential in chronic eosinophilic pneumonia. J Allergy Clin Immunol 1986; 79: 755-762.
8. Ayars GH, Altman LC, Gleich GJ, Loegering DA, Baker CB. Eosinophil- and eosinophil granule-mediated pneumocyte injury. J Allergy Clin Immunol 1985; 76: 595-604.
9. Davis WB, Fells GA, Sun XH, Gadek JE, Venet A, Crystal RG. Eosinophil-mediated injury to lung parenchymal cells and interstitial matrix: a possible role for eosinophils in chronic inflammatory disorders of the lower respiratory tract. J Clin Invest 1984; 74: 269-278.
10. Abu Ghazaleh RI, Fujisawa T, Mestecky J, Kyle RA, Gleich GJ. IgA-induced eosinophil degranulation. J Immunol 1989; 142: 2393-2400.
11. Tomassini M, Tsicopoulos A, Tai PC, et al. Release of granule proteins by eosinophils from allergic and nonallergic patients with eosinophilia on immunoglobulindependent activation. J Allergy Clin Immunol 1991; 88: 365-375.
12. Tai PC, Capron M, Bakes DM, Barkans J, Spry CJ. Monoclonal antibodies to human eosinophil plasma membrane antigens enhance the secretion of eosinophil cationic protein. Clin Exp Immunol 1986; 63: 728-737.
13. Gustafsson R, Fredens K, Nettelbladt O, Hallgren R. Eosinophil activation in systemic sclerosis. Arthritis Rheum 1991; 34: 414-422.
14. Hallgren R, Bjermer L, Lundgren R, Venge P. The eosinophil component of the alveolitis in idiopathic pulmonary fibrosis: signs of eosinophil activation in the lung are related to impaired lung function. Am Rev RespirDis 1989; 139: 373-377.
15. Hallgren R, Samuelsson T, Venge P, Modig J. Eosinophil activation in the lung is related to lung damage in adult respiratory distress syndrome. Am Rev Respir Dis 1987; 135: 639-642.
16. Janin A, Torpier G, Courtin P, et al. Segregation of eosinophil proteins in alveolar macrophage compartments in chronic eosinophilic pneumonia. Thorax 1993; 48: 57-62.
17. Shijubo N, Shigehara K, Hirasawa M, Inuzuka M, Abe S. Eosinophilic cationic protein in chronic eosinophilic pneumonia and eosinophilic granuloma. Chest 1994; 106: 1481-1486.
18. American Thoracic Society. Medical section of the American Lung Association: standards for the diagnosis and care of patients with chronic obstructive pulmonary disease (COPD) and asthma. Am Rev Respir Dis 1987; 137: 225-244.
19. Drent M, Mulder PG, Wagenaar SjSc, Hoogsteden HC, van Velzen Blad H, van den Bosch JM. Differences in BAL fluid variables in interstitial lung diseases evaluated by discriminant analysis. Eur Respir J 1993; 6: 803-810.
20. Kelly CA, Fenwick JD, Corris PA, Fleetwood A, Hendrick DJ, Walters EH. Fluid dynamics during bronchoalveolar lavage. Am Rev Respir Dis 1988; 138: 81-84.
21. Jones KP, Edwards JH, Reynolds SP, Peters TJ, Davies BH. A comparison of albumin and urea as reference markers in bronchoalveolar lavage fluid from patients with interstitial lung disease. Eur Respir J 1989; 3: 152-156.
22. Yoshida K, Shijubo N, Koba H, et al. Chronic eosinophilic pneumonia progressing to lung fibrosis. Eur Respir J 1994; 7: 1541-1544.
23. Venge P, Henriksen J, Dabl R. Eosinophils in exerciseinduced asthma. J Allergy Clin Immunol 1991; 88: 699-704.
24. Rak S, Bjornson A, Hakanson L, Sorenson S, Venge P. The effect of immunotherapy on eosinophil accumulation and production of eosinophil chemotactic activity in the lung of subjects with asthma during the natural pollen season. Eur Respir J 1991; 88: 878-888.
25. Kroegel C, Virchow JCJ, Luttmann W, Walker C, Warner JA. Pulmonary immune cells in health and disease: the eosinophil leucocyte. Part I. Eur Respir J 1994; 7: 519-543.
26. Kerr MA. The structure and function of human IgA. Review article. Biochem J 1990; 271: 285-296.
27. Pesci A, Bertorelli G, Manganelli P, et al. Bronchoalveolar lavage in chronic eosinophilic pneumonia: analysis of six cases in comparison with other interstitial lung diseases. Respiration 1988; 54 (Suppl. 1): 16-22.
28. Out TA, van de Graaf EA, Jansen HM. Permeability or local production of immunoglobulins and other inflammatory proteins in asthma. Eur Respir J 1991; 13 (Suppl.): 148s-155s.